Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ.

Powell E, Shanle E, Brinkman A, Li J, Keles S, Wisinski KB, Huang W, Xu W.

PLoS One. 2012;7(2):e30993. doi: 10.1371/journal.pone.0030993. Epub 2012 Feb 7.

2.

Estrogen receptor beta in breast cancer.

Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Wärri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M, Gustafsson JA.

Endocr Relat Cancer. 2002 Mar;9(1):1-13. Review.

3.

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.

J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. Review.

PMID:
11162936
4.

Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.

Skliris GP, Leygue E, Watson PH, Murphy LC.

J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):1-10. doi: 10.1016/j.jsbmb.2007.12.010. Epub 2007 Dec 8. Review.

PMID:
18243688
5.

Estrogen receptor beta in breast cancer--diagnostic and therapeutic implications.

Hartman J, Ström A, Gustafsson JA.

Steroids. 2009 Aug;74(8):635-41. doi: 10.1016/j.steroids.2009.02.005. Epub 2009 Mar 4. Review.

PMID:
19463683
6.

Estrogen signaling: a subtle balance between ER alpha and ER beta.

Matthews J, Gustafsson JA.

Mol Interv. 2003 Aug;3(5):281-92. Review.

PMID:
14993442
7.

ERbeta in breast cancer--onlooker, passive player, or active protector?

Fox EM, Davis RJ, Shupnik MA.

Steroids. 2008 Oct;73(11):1039-51. doi: 10.1016/j.steroids.2008.04.006. Epub 2008 Apr 20. Review.

8.

Selectively targeting estrogen receptors for cancer treatment.

Shanle EK, Xu W.

Adv Drug Deliv Rev. 2010 Oct 30;62(13):1265-76. doi: 10.1016/j.addr.2010.08.001. Epub 2010 Aug 10. Review.

9.

Estrogen receptor α and β in the normal immune system and in lymphoid malignancies.

Yakimchuk K, Jondal M, Okret S.

Mol Cell Endocrinol. 2013 Aug 15;375(1-2):121-9. doi: 10.1016/j.mce.2013.05.016. Epub 2013 May 23. Review.

PMID:
23707618
10.

Estrogen receptors: selective ligands, partners, and distinctive pharmacology.

Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA.

Recent Prog Horm Res. 2000;55:163-93; discussion 194-5. Review.

PMID:
11036937
11.

[New insights into the role of estogens and their receptors in prostate cancer].

Bonkhoff H, Motherby H, Fixemer T.

Urologe A. 2003 Dec;42(12):1594-601. Review. German.

PMID:
14668987
12.

[Estrogen receptor expression in tumors different from breast cancer].

Bogush TA, Dudko EA, Beme AA, Bogush EA, Polotskiĭ BE, Tiuliandin SA, Davydov MI.

Antibiot Khimioter. 2009;54(7-8):41-9. Review. Russian.

PMID:
20201403
13.

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.

Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P.

Endocr Relat Cancer. 2004 Sep;11(3):537-51. Review.

14.

Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects.

Omoto Y, Iwase H.

Cancer Sci. 2015 Apr;106(4):337-43. doi: 10.1111/cas.12613. Epub 2015 Mar 9. Review.

15.

ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.

Chen JQ, Russo J.

Biochim Biophys Acta. 2009 Dec;1796(2):162-75. doi: 10.1016/j.bbcan.2009.06.003. Epub 2009 Jun 13. Review.

16.

Cancer therapy using natural ligands that target estrogen receptor beta.

Sareddy GR, Vadlamudi RK.

Chin J Nat Med. 2015 Nov;13(11):801-7. doi: 10.1016/S1875-5364(15)30083-2. Review.

17.

The role of estrogens and estrogen receptors in normal prostate growth and disease.

Prins GS, Korach KS.

Steroids. 2008 Mar;73(3):233-44. Epub 2007 Nov 12. Review.

18.

Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility.

Marzagalli M, Montagnani Marelli M, Casati L, Fontana F, Moretti RM, Limonta P.

Front Endocrinol (Lausanne). 2016 Oct 26;7:140. eCollection 2016. Review.

19.

Estrogen receptor-beta and breast cancer: translating biology into clinical practice.

Leung YK, Lee MT, Lam HM, Tarapore P, Ho SM.

Steroids. 2012 Jun;77(7):727-37. doi: 10.1016/j.steroids.2012.03.008. Epub 2012 Mar 29. Review.

20.

Estrogen receptor β ligands: recent advances and biomedical applications.

Minutolo F, Macchia M, Katzenellenbogen BS, Katzenellenbogen JA.

Med Res Rev. 2011 May;31(3):364-442. doi: 10.1002/med.20186. Review.

PMID:
19967775

Supplemental Content

Support Center